Study on mechanism of quinolones resistance in Acinetobacter baumannii

Chinese Journal of Infection and Chemotherapy

Volumn 8, Issue 4, 2008, Pages 266-270

  Wang, Yan Li ^a   Huang, Mao ^a   Mei, Ya Ning ^a   Yin, Kai Sheng ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Acinetobacter baumannii; adeABC; gyrA; parC; Quinolones resistance

Indexed keywords

BACTERIAL PROTEIN; CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; IMIPENEM; MESSENGER RNA; PROTEIN ADEB; PROTEIN PARC; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BROTH DILUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE AMPLIFICATION; GENE MUTATION; GENE OVEREXPRESSION; GENE SEQUENCE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; REAL TIME POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SPUTUM ANALYSIS; STRAIN DIFFERENCE;

EID: 52049088548     PISSN: 10097708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Poole K. Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria [J]. Antimicrob Agents Chemother, 2000,44 (9):2233-2241.
2. Vila J, Ruiz J, Goni P, et al. Quinolone-resistance mutations in the topoisomerase IV praC gene of Acinetobacter baumanni [J]. J Antimicrob Chemother,1997,39(6):757-762.
3. Chinese source.
4. Magnet S, Courvalin P, Lambert T. Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454 [J]. Antimicrob Agents Chemother, 2001, 45(12):3375-3380.
5. Marchand I, Damier-Piolle L, Courvalin P, et al. Expression of the RND-type efflux pump AdeABC in Acinetobacter baumannii is regulated by the AdeRS two-component system [J]. Antimicrob Agents Chemother, 2004, 48(9):3298-3304.
6. Chu YW, Chau SL, Houang ET. Presence of active efflux systems AdeABC, AdeDE and AdeXYZ in different Acinetobacter genomic DNA groups [J]. J Med Microbiol, 2006, 55 (Pt 4):477-478.
7. Ruzin A, Keeney D, Bradford PA. AdeABC multidurg efflux pump is associated with decreased susceptibility to tigecycline in Acinetobacter calcoaceticus- Acinetobacter baumannii complex [J]. J Antimicrob Chemother, 2007, 59(5):1001-1004.
8. Heritier C, Poirel L, Lambert T, et al. Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenenm resistance in Acinetobacter baumannii[J]. Antimicrob Agents Chemother, 2005, 49(8):3198-3202.
9. Piddock LJ. Clinically relevant chromosomally encoded multidrug resistance dfflux pumps in bacteria [J]. Clin Microbiol Rev, 2006, 19(2):382-402.
10. Higgins PG, Wisplinghoff H, Stefanik D, et al. Selection of topoisomerase mutations and overexpression of adeB mRNA transcripts during an outbreak of Acinetobacter baumannii [J]. J Antimicrob Chemother, 2004, 54(4):821-823.
11. Nemec A, Maixnerova M, van der Reijden TJ, et al. Relationship between the AdeABC efflux system gene content, netilmicin susceptibility and multidrug resistance in a genotypically diverse collection of Acinetobacter baumannii strains [J]. J Antimicrob Chemother, 2007,60(3):483-489.
12. Martinez-Martinez L, Pascual A, Jacoby GA. Quinolone resistance from a transferable plasmid [J]. Lancet, 1998, 351 (9105):797-799.
13. Robicsek A, Sahm DF, Strahilevitz J, et al. Brodaer distribution of plasmid-mediated quinolone resistance in the United States [J]. Antimicrob Agents Chemother, 2005, 49 (7): 3001-3003.